BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaur K, Nanut MP, Ko MW, Safaie T, Kos J, Jewett A. Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy. Curr Opin Immunol 2018;51:170-80. [PMID: 29653339 DOI: 10.1016/j.coi.2018.03.022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Hu Z, Xu X, Wei H. The Adverse Impact of Tumor Microenvironment on NK-Cell. Front Immunol 2021;12:633361. [PMID: 34177887 DOI: 10.3389/fimmu.2021.633361] [Reference Citation Analysis]
2 Zhao Q, Pang J, Yan F, Jiang Y, Cui D, Liu J, Jing L, Li Y, Liu Z, Tao L, Zhao X, Diao A. Production of a novel bispecific protein ULBP1×CD19-scFv targeting the NKG2D receptor and CD19 to promote the activation of NK cells. Protein Expr Purif 2021;178:105783. [PMID: 33122138 DOI: 10.1016/j.pep.2020.105783] [Reference Citation Analysis]
3 Jewett A, Kos J, Kaur K, Safaei T, Sutanto C, Chen W, Wong P, Namagerdi AK, Fang C, Fong Y, Ko MW. Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis. Mol Ther Oncolytics 2020;16:41-52. [PMID: 31930165 DOI: 10.1016/j.omto.2019.11.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
4 Lee JY, Chaudhuri O. Modeling the tumor immune microenvironment for drug discovery using 3D culture. APL Bioeng 2021;5:010903. [PMID: 33564739 DOI: 10.1063/5.0030693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Park DJ, Sung PS, Kim JH, Lee GW, Jang JW, Jung ES, Bae SH, Choi JY, Yoon SK. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1. J Immunother Cancer 2020;8:e000301. [PMID: 32221015 DOI: 10.1136/jitc-2019-000301] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
6 Jewett A. The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions. Front Immunol 2020;11:1692. [PMID: 32754162 DOI: 10.3389/fimmu.2020.01692] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
7 Jakoš T, Pišlar A, Pečar Fonović U, Kos J. Lysosomal peptidases in innate immune cells: implications for cancer immunity. Cancer Immunol Immunother 2020;69:275-83. [PMID: 31813053 DOI: 10.1007/s00262-019-02447-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Seki T, Shimizu Y, Ishii K, Takahama Y, Kato K, Yano T. NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway. Biomolecules 2021;11:1702. [PMID: 34827699 DOI: 10.3390/biom11111702] [Reference Citation Analysis]
9 Soond SM, Zamyatnin AA Jr. Helicobacter pylori and gastric cancer: a lysosomal protease perspective. Gastric Cancer 2021. [PMID: 34918208 DOI: 10.1007/s10120-021-01272-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Melaiu O, Lucarini V, Cifaldi L, Fruci D. Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors. Front Immunol 2019;10:3038. [PMID: 32038612 DOI: 10.3389/fimmu.2019.03038] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 32.0] [Reference Citation Analysis]
11 Prunk M, Perišić Nanut M, Jakoš T, Sabotič J, Švajger U, Kos J. Extracellular Cystatin F Is Internalised by Cytotoxic T Lymphocytes and Decreases Their Cytotoxicity. Cancers (Basel) 2020;12:E3660. [PMID: 33291222 DOI: 10.3390/cancers12123660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Choucair K, Duff JR, Cassidy CS, Albrethsen MT, Kelso JD, Lenhard A, Staats H, Patel R, Brunicardi FC, Dworkin L, Nemunaitis J. Natural killer cells: a review of biology, therapeutic potential and challenges in treatment of solid tumors. Future Oncology 2019;15:3053-69. [DOI: 10.2217/fon-2019-0116] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
13 Leivas A, Risueño RM, Guzmán A, Sánchez-Vega L, Pérez M, Megías D, Fernández L, Alonso R, Pérez-Martínez A, Rapado I, Martínez-López J. Natural killer cells efficiently target multiple myeloma clonogenic tumor cells. Cancer Immunol Immunother 2021;70:2911-24. [PMID: 33693963 DOI: 10.1007/s00262-021-02901-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Perišić Nanut M, Pečar Fonović U, Jakoš T, Kos J. The Role of Cysteine Peptidases in Hematopoietic Stem Cell Differentiation and Modulation of Immune System Function. Front Immunol 2021;12:680279. [PMID: 34335582 DOI: 10.3389/fimmu.2021.680279] [Reference Citation Analysis]
15 Ruiu R, Tarone L, Rolih V, Barutello G, Bolli E, Riccardo F, Cavallo F, Conti L. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source. Prog Mol Biol Transl Sci 2019;164:119-88. [PMID: 31383404 DOI: 10.1016/bs.pmbts.2019.03.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
16 Weng J, Han X, Liu K, Yang J, Wei S, Zhang Y, Zeng F, Li Y, Shen L, Gao Y. CD44 3'-Untranslated Region Functions as a Competing Endogenous RNA to Enhance NK Sensitivity of Liver Cancer Stem Cell by Regulating ULBP2 Expression. Int J Biol Sci 2019;15:1664-75. [PMID: 31360109 DOI: 10.7150/ijbs.35216] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
17 Elaraby E, Malek AI, Abdullah HW, Elemam NM, Saber-Ayad M, Talaat IM. Natural Killer Cell Dysfunction in Obese Patients with Breast Cancer: A Review of a Triad and Its Implications. J Immunol Res 2021;2021:9972927. [PMID: 34212054 DOI: 10.1155/2021/9972927] [Reference Citation Analysis]
18 Kaur K, Safaie T, Ko MW, Wang Y, Jewett A. ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor. Cancers (Basel) 2021;13:E239. [PMID: 33440654 DOI: 10.3390/cancers13020239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Kaur K, Chang HH, Topchyan P, Cook JM, Barkhordarian A, Eibl G, Jewett A. Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice. Front Immunol. 2018;9:1229. [PMID: 29977235 DOI: 10.3389/fimmu.2018.01229] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
20 Belizário JE, Neyra JM, Setúbal Destro Rodrigues MF. When and how NK cell-induced programmed cell death benefits immunological protection against intracellular pathogen infection. Innate Immun 2018;24:452-65. [PMID: 30236030 DOI: 10.1177/1753425918800200] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
21 Capuano C, Pighi C, Battella S, De Federicis D, Galandrini R, Palmieri G. Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs. Cancers (Basel) 2021;13:2500. [PMID: 34065399 DOI: 10.3390/cancers13102500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Wu Z, Zhang C, Najafi M. Targeting of the tumor immune microenvironment by metformin. J Cell Commun Signal 2021. [PMID: 34611852 DOI: 10.1007/s12079-021-00648-w] [Reference Citation Analysis]
23 Kaur K, Kozlowska AK, Topchyan P, Ko MW, Ohanian N, Chiang J, Cook J, Maung PO, Park SH, Cacalano N, Fang C, Jewett A. Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice. Cancers (Basel) 2019;12:E63. [PMID: 31878338 DOI: 10.3390/cancers12010063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
24 Kaur K, Kanayama K, Wu Q, Gumrukcu S, Nishimura I, Jewett A. Zoledronic acid mediated differential activation of NK cells in different organs of WT and Rag2 mice; stark differences between the bone marrow and gingivae. Cellular Immunology 2022. [DOI: 10.1016/j.cellimm.2022.104526] [Reference Citation Analysis]
25 Jewett A, Kos J, Fong Y, Ko MW, Safaei T, Perišić Nanut M, Kaur K. NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis. Semin Cancer Biol 2018;53:178-88. [PMID: 30081230 DOI: 10.1016/j.semcancer.2018.08.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]